References
Højgaard L. Are Health Technology Assessments a reliable tool in the analysis of the clinical value of PET in oncology? Who audits the auditors? Eur J Nucl Med Mol Imaging 2003; 30:637–641.
Fuchs VR, Garber AM. The New Technology Assessment. N Engl J Med 1990; 323:673–677.
Steinberg EP. Magnetic resonance coronary angiography—assessing an emerging technology. N Engl J Med 1993; 328:879–880.
van Tinteren H, Hoekstra OS, Smit EF, van den Bergh JH, Schreurs AJ, Stallaert RA, van Velthoven PC, Comans EF, Diepenhorst FW, Verboom P, van Mourik JC, Postmus PE, Boers M, Teule GJ. Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial. Lancet 2002; 359:1388–1393.
Author information
Authors and Affiliations
Corresponding author
Additional information
An author's reply to this letter is available at http://dx.doi.org/10.1007/s00259-003-1295-x
Rights and permissions
About this article
Cite this article
Van Tinteren, H., Hoekstra, O.S. & Boers, M. The need for Health Technology Assessments of PET. Eur J Nucl Med Mol Imaging 30, 1438 (2003). https://doi.org/10.1007/s00259-003-1294-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00259-003-1294-y